Justin Zelin

Justin Zelin

Analyst-Equity at BTIG LLC

Finance
Consumer Services
Health Technology

Profile

Mr. Justin Zelin is a Director at BTIG LLC.
His research coverage focuses on the biotechnology sector, where he specializes in cell therapy, targeted oncology, immunology and auto-immune disease therapeutics.
Prior to BTIG, Mr. Zelin was a Biotech Equity Research Analyst at B.
Riley Securities.
Previously, he held biotech equity research associate roles at Canaccord Genuity and SVB Leerink.
Earlier in his career, Mr. Zelin worked in both academic and industry labs including Agenus, Harvard University and Brigham and Women’s Hospital.
He was also a member of Harvard University’s teaching staff for more than five years.
He earned a master’s degree in biotechnology and a bachelor’s degree in biology from Harvard University.

Justin Zelin active positions

CompaniesPositionStart
Analyst-Equity 2020-12-31
All active positions of Justin Zelin

Former positions of Justin Zelin

CompaniesPositionEnd
Analyst-Equity 2020-11-30
Analyst-Equity 2020-06-30
Corporate Officer/Principal 2019-03-31
AGENUS INC. Corporate Officer/Principal 2016-08-31
See the detail of Justin Zelin's experience

Training of Justin Zelin

Harvard University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Justin Zelin's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AGENUS INC.

Health Technology

Private companies4

Finance

Finance

Finance

Finance

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW